Summary
In a significant market movement during April 2017, ALung Technologies was the subject of a vc funding. The transaction achieved a gross valuation of £28,770,159. Leading the round was Philips, Abiomed, UPMC, Allos Ventures, Birchmere Ventures, The Accelerator Group, Blue Tree Ventures, and Riverfront Ventures..
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Philips
Lead Investor / Acquirer
Abiomed
Lead Investor / Acquirer
UPMC
Lead Investor / Acquirer
Allos Ventures
Lead Investor / Acquirer
Birchmere Ventures
Lead Investor / Acquirer
The Accelerator Group
Lead Investor / Acquirer
Blue Tree Ventures
Lead Investor / Acquirer
Riverfront Ventures.
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series C prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in